We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.55%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$48B
AUM Growth
-$1.59B
(-3.2%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-3.05%
Top 10 Holdings %
Top 10 Hldgs %
24.06%
Holding
1,904
New
84
Increased
534
Reduced
502
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$60.6M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.8M |
| 3 |
Mastercard
MA
|
+$43.1M |
| 4 |
Analog Devices
ADI
|
+$40.3M |
| 5 |
Broadcom
AVGO
|
+$40.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$92.3M |
| 2 |
NVIDIA
NVDA
|
+$92.1M |
| 3 |
Eli Lilly
LLY
|
+$80.8M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$74.2M |
| 5 |
Microsoft
MSFT
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.14% |
| 2 | Financials | 15.08% |
| 3 | Healthcare | 14.69% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Communication Services | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Quanterix
QTRX
$165M
| $10.2M | 0.02% |
205,709
-41,051
| -17% | -$2.12M |
|
427
AstraZeneca
AZN
$266B
| $10.2M | 0.02% |
85,064
+2,709
| +3% | +$315K |
|
|
AXON
428
Axon Enterprise
AXON
$43.8B
| $10.1M | 0.02% |
57,669
+4,180
| +8% | +$759K |
|
|
DOCU
429
DocuSign
DOCU
$10.7B
| $10.1M | 0.02% |
39,037
+6,050
| +18% | +$1.74M |
|
430
Progressive
PGR
$129B
| $10M | 0.02% |
111,095
-5,836
| -5% | -$556K |
|
|
XM
431
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $9.98M | 0.02% |
233,450
+14,770
| +7% | +$625K |
|
432
XPO
XPO
$24.3B
| $9.91M | 0.02% |
209,562
-147,806
| -41% | -$7.41M |
|
433
Toro Company
TTC
$9.07B
| $9.87M | 0.02% |
101,288
+915
| +0.9% | +$99.8K |
|
434
Nordson
NDSN
$16.8B
| $9.83M | 0.02% |
41,259
+355
| +0.9% | +$82K |
|
435
CMS Energy
CMS
$23.2B
| $9.8M | 0.02% |
164,177
+17,607
| +12% | +$1.1M |
|
436
Hilton Worldwide
HLT
$73.3B
| $9.77M | 0.02% |
73,911
-26,223
| -26% | -$3.31M |
|
437
Carlisle Companies
CSL
$14B
| $9.71M | 0.02% |
48,862
+3,575
| +8% | +$721K |
|
438
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.8B
| $9.66M | 0.02% |
107,666
+32,952
| +44% | +$2.99M |
|
439
GXO Logistics
GXO
$6.1B
| $9.66M | 0.02% |
+123,097
| New | +$9.65M |
|
440
First Horizon
FHN
$12.2B
| $9.58M | 0.02% |
588,075
+4,530
| +0.8% | +$72.2K |
|
441
Steris
STE
$22.3B
| $9.53M | 0.02% |
46,634
+1,746
| +4% | +$374K |
|
442
Essential Utilities
WTRG
$11.6B
| $9.5M | 0.02% |
206,250
+3,000
| +1% | +$145K |
|
443
Lamar Advertising Co
LAMR
$16.5B
| $9.5M | 0.02% |
83,756
-3,085
| -4% | -$338K |
|
444
Everest Group
EG
$15.8B
| $9.47M | 0.02% |
37,768
+4,808
| +15% | +$1.23M |
|
445
Lithia Motors
LAD
$8.15B
| $9.47M | 0.02% |
29,878
+4,045
| +16% | +$1.41M |
|
|
WRK
446
DELISTED
WestRock Company
WRK
| $9.47M | 0.02% |
190,076
-38,862
| -17% | -$1.96M |
|
|
KRON
447
DELISTED
Kronos Bio
KRON
| $9.37M | 0.02% |
447,215
-33,954
| -7% | -$729K |
|
448
Otis Worldwide
OTIS
$28.1B
| $9.33M | 0.02% |
113,447
-63,113
| -36% | -$5.55M |
|
449
Arcutis Biotherapeutics
ARQT
$3.54B
| $9.32M | 0.02% |
389,938
-7,278
| -2% | -$166K |
|
450
Healthpeak Properties
DOC
$15.8B
| $9.22M | 0.02% |
275,338
-13,276
| -5% | -$470K |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Ensign Peak Advisors held 1,904 positions worth $48B, down 3.2% from $49.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ensign Peak Advisors withdrew a net $1.46B in Q3 2021, closing 55 positions and reducing 502 holdings. Its most notable exit was Root, an estimated $29.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ensign Peak Advisors opened a new position in State Street SPDR S&P Biotech ETF worth $37.7M.
- Ensign Peak Advisors's largest Q3 2021 buy was State Street SPDR S&P Biotech ETF: 300,000 shares worth $37.7M.
- Ensign Peak Advisors added most to AbbVie in Q3 2021, an estimated $60.6M increase.
- Ensign Peak Advisors's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $92.3M.
- Ensign Peak Advisors fully exited Root in Q3 2021, selling an estimated $29.6M.
- Ensign Peak Advisors's ten largest holdings make up 24% of its $48B portfolio in Q3 2021.
- Ensign Peak Advisors opened 84 new positions and closed 55 in Q3 2021.
- Ensign Peak Advisors's portfolio value fell 3.2% quarter-over-quarter to $48B.
Based on Ensign Peak Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.